TC-2153 is primarily researched for its potential therapeutic applications, particularly in the field of neurodegenerative diseases and cognitive disorders. It is known to inhibit STEP (STriatal-Enriched protein tyrosine Phosphatase), an enzyme implicated in the regulation of synaptic plasticity and neuronal signaling. By inhibiting STEP, TC-2153 may help enhance cognitive function and memory, making it a promising candidate for treating conditions like Alzheimer's disease. Additionally, its role in modulating neuronal pathways suggests potential benefits in addressing other neurological and psychiatric disorders, such as Parkinson's disease and depression. Research is ongoing to further explore its efficacy and safety in clinical settings.